BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 28465481)

  • 21. Network-based analysis identifies epigenetic biomarkers of esophageal squamous cell carcinoma progression.
    Cheng CP; Kuo IY; Alakus H; Frazer KA; Harismendy O; Wang YC; Tseng VS
    Bioinformatics; 2014 Nov; 30(21):3054-61. PubMed ID: 25015989
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF
    Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTEN gene is infrequently hypermethylated in human esophageal squamous cell carcinoma.
    Sun Z; Ji N; Bi M; Wang S; Liu X; Wang Z
    Tumour Biol; 2015 Aug; 36(8):5849-57. PubMed ID: 25724185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
    Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma.
    Yue D; Fan Q; Chen X; Li F; Wang L; Huang L; Dong W; Chen X; Zhang Z; Liu J; Wang F; Wang M; Zhang B; Zhang Y
    Exp Cell Res; 2014 Mar; 322(1):149-58. PubMed ID: 24269829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosomal instability associated with global DNA hypomethylation is associated with the initiation and progression of esophageal squamous cell carcinoma.
    Kawano H; Saeki H; Kitao H; Tsuda Y; Otsu H; Ando K; Ito S; Egashira A; Oki E; Morita M; Oda Y; Maehara Y
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S696-702. PubMed ID: 24898425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA Methylation Status of PAX1 and ZNF582 in Esophageal Squamous Cell Carcinoma.
    Huang J; Wang G; Tang J; Zhuang W; Wang LP; Liou YL; Liu YZ; Zhou HH; Zhu YS
    Int J Environ Res Public Health; 2017 Feb; 14(2):. PubMed ID: 28241446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant methylation-mediated downregulation of long noncoding RNA LOC100130476 correlates with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Shi Y; Liu S; Liang J; Guo Y; Guo X; Shen S; Shan B
    Dig Liver Dis; 2016 Aug; 48(8):961-9. PubMed ID: 27338851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions.
    Roth MJ; Abnet CC; Hu N; Wang QH; Wei WQ; Green L; D'Alelio M; Qiao YL; Dawsey SM; Taylor PR; Woodson K
    Oncol Rep; 2006 Jun; 15(6):1591-7. PubMed ID: 16685400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new classification of lymph node metastases according to the lymph node stations for predicting prognosis in surgical patients with esophageal squamous cell carcinoma.
    Lin Z; Chen W; Chen Y; Peng X; Zhu K; Lin Y; Lin Q; Hu Z
    Oncotarget; 2016 Nov; 7(46):76261-76273. PubMed ID: 27788489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of PLCE1 in Kazakh esophageal squamous cell carcinoma: implications in cancer metastasis and aggressiveness.
    Chen YZ; Cui XB; Hu JM; Zhang WJ; Li SG; Yang L; Shen XH; Liu CX; Pan QF; Yu SY; Yuan XL; Yang L; Gu WY; Chen JZ; Wang LD; Li F
    APMIS; 2013 Oct; 121(10):908-18. PubMed ID: 23659763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome.
    Hoshimoto S; Takeuchi H; Ono S; Sim MS; Huynh JL; Huang SK; Marzese DM; Kitagawa Y; Hoon DS
    J Thorac Oncol; 2015 Mar; 10(3):509-17. PubMed ID: 25514805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation and expression of PTPN22 in esophageal squamous cell carcinoma.
    Deng J; Zhang J; Wang Ch; Wei Q; Zhou D; Zhao K
    Oncotarget; 2016 Sep; 7(39):64043-64052. PubMed ID: 27613842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of miR-34a by aberrant CpG methylation in Kazakh patients with esophageal carcinoma.
    Cui X; Zhao Z; Liu D; Guo T; Li S; Hu J; Liu C; Yang L; Cao Y; Jiang J; Liang W; Liu W; Li S; Wang L; Wang L; Gu W; Wu C; Chen Y; Li F
    J Exp Clin Cancer Res; 2014 Feb; 33(1):20. PubMed ID: 24528540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.
    Li P; Liu X; Dong ZM; Ling ZQ
    Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic alterations of the Igf2 promoter and the effect of miR‑483‑5p on its target gene expression in esophageal squamous cell carcinoma.
    Zhang H; Shi X; Chang W; Li Y; Wang L; Wang L
    Mol Med Rep; 2018 Feb; 17(2):2251-2256. PubMed ID: 29207103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nomogram for prediction of lymph node metastasis in patients with superficial esophageal squamous cell carcinoma.
    Min BH; Yang JW; Min YW; Baek SY; Kim S; Kim HK; Choi YS; Shim YM; Choi YL; Zo JI
    J Gastroenterol Hepatol; 2020 Jun; 35(6):1009-1015. PubMed ID: 31674067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant DNA methylation of PAX1, SOX1 and ZNF582 genes as potential biomarkers for esophageal squamous cell carcinoma.
    Tang L; Liou YL; Wan ZR; Tang J; Zhou Y; Zhuang W; Wang G
    Biomed Pharmacother; 2019 Dec; 120():109488. PubMed ID: 31629253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-DRB1 and HLA-DQB1 methylation changes promote the occurrence and progression of Kazakh ESCC.
    Hu JM; Li L; Chen YZ; Liu C; Cui X; Yin L; Yang L; Zou H; Pang L; Zhao J; Qi Y; Cao Y; Jiang J; Liang W; Li F
    Epigenetics; 2014 Oct; 9(10):1366-73. PubMed ID: 25437052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic silencing of miR-203 in Kazakh patients with esophageal squamous cell carcinoma by MassARRAY spectrometry.
    Cui X; Chen X; Wang W; Chang A; Yang L; Liu C; Peng H; Wei Y; Liang W; Li S; Wang N; Liu W; Hu J; Zhang W; Wang L; Chen Y; Li F
    Epigenetics; 2017 Aug; 12(8):698-707. PubMed ID: 28703658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.